Relationship between serum lipid values and atherosclerotic burden in the proximal thoracic aorta

International Journal of Stroke

Volumn 5, Issue 4, 2010, Pages 257-263

  Kohsaka, Shun ^a   Jin, Zhezhen ^b   Rundek, Tatjana ^c   Homma, Shunichi ^a   Sacco, Ralph L ^c   Di Tullio, Marco R ^a  

^a Department of Medicine Division of Cardiology College of Physicians and Surgeons Columbia University ^*  (United States)

^b Department of Biostatistics Mailman School of Public Health Columbia University ^*  (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoproteins; Atherosclerosis; Cardio aortic embolism; Lipids; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

AGED; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE PATIENT; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; ANATOMY; ATHEROSCLEROSIS; BLOOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; STROKE; UNITED STATES;

AGED; ANATOMY, CROSS-SECTIONAL; ANTICHOLESTEREMIC AGENTS; AORTA, THORACIC; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHOLESTEROL, HDL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; NEW YORK CITY; PROGNOSIS; RISK FACTORS; STROKE; TRIGLYCERIDES;

EID: 77955153615     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00437.x     Document Type: Article

References (40)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Jama 2001, 285:2486-97.
2. Nissen SE, Tuzcu EM, Schoenhagen P. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. Jama 2004, 291:1071-80.
3. LaRosa JC, Grundy SM, Waters DD. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005, 352:1425-35.
4. Amarenco P, Bogousslavsky J, Callahan A. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-59.
5. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002, 324:1570-6.
6. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study. Am J Cardiol 1992, 70:733-7.
7. Gordon DJ, Probstfield JL, Garrison RJ. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989, 79:8-15.
8. Barter P, Gotto AM, LaRosa JC. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007, 357:1301-10.
9. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001, 358:2026-33.
10. Yusuf S, Hawken S, Ounpuu S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-52.
11. Karalis DG, Chandrasekaran K, Victor MF, Ross JJ, Mintz GS. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 1991, 17:73-8.
12. Khatibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996, 27:664-9.
13. Di Tullio MR, Sacco RL, Gersony D. Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996, 46:1560-6.
14. Amarenco P, Cohen A, Tzourio C. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474-9.
15. Di Tullio MR, Homma S, Jin Z, Sacco RL. Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol 2008, 52:855-61.
16. Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S. Aortic arch plaques and risk of recurrent stroke and death. Circulation 2009, 119:2376-82.
17. Fujimoto S, Yasaka M, Otsubo R, Oe H, Nagatsuka K, Minematsu K. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004, 35:1426-9.
18. Sacco RL, Anand K, Lee HS. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan study. Stroke 2004, 35:2263-9.
19. Gentry EM, Kalsbeek WD, Hogelin GC. The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med 1985, 1:9-14.
20. Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J 2000, 139:329-36.
21. Tribouilloy CM, Peltier M, Iannetta-Peltier MC, Zhu Z, Andrejak M, Lesbre JP. Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis. Am J Cardiol 1999, 84:603-5. A9
22. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol 1993, 21:144-50.
23. Khoury Z, Gottlieb S, Stern S, Keren A. Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am J Cardiol 1997, 79:23-7.
24. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006, 98:1352-64.
25. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004, 95:764-72.
26. Johnsen SH, Mathiesen EB, Fosse E. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study. Circulation 2005, 112:498-504.
27. Goldstein LB, Adams R, Alberts MJ. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006, 113:e873-923.
28. Kastelein JJ, van Leuven SI, Burgess L. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 2007, 356:1620-30.
29. Ashen MD, Blumenthal RS. Clinical practice. Low HDL cholesterol levels. N Engl J Med 2005, 353:1252-60.
30. Barter PJ, Caulfield M, Eriksson M. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007, 357:2109-22.
31. Drexel H. Nicotinic acid in the treatment of hyperlipidaemia. Fundam Clin Pharmacol 2007, 21((Suppl. 2)):5-6.
32. Frontini MG, Srinivasan SR, Xu JH, Tang R, Bond MG, Berenson G. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study). Am J Cardiol 2007, 100:64-8.
33. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134:250-6.
34. Kofoed SC, Gronholdt ML, Bismuth J, Wilhjelm JE, Sillesen H, Nordestgaard BG. Echolucent, rupture-prone carotid plaques associated with elevated triglyceride-rich lipoproteins, particularly in women. J Vasc Surg 2002, 36:783-92.
35. Mathiesen EB, Bonaa KH, Joakimsen O. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: the Tromso study. Stroke 2001, 32:1960-5.
36. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med 1981, 141:1128-31.
37. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 1994, 309:11-5.
38. Rundek T, White H, Boden-Albala B, Jin Z, Elkind MS, Sacco RL. The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometab Syndr 2007, 2:24-9.
39. De Castro S, Di Angelantonio E, Celotto A. Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study. Eur J Echocardiogr 2009, 10:96-102.
40. Sen S, Oppenheimer SM, Lima J, Cohen B. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke 2002, 33:930-5.